Meet the Scientific Minds

Principal Investigator, BCI Lab

Johns Hopkins University

Dr. Osei develops brain-computer interface systems for restoring motor function in paralyzed patients, with three ongoing FDA-approved clinical trials.

VP of Clinical Development

Novartis Oncology

Dr. Beaumont has overseen regulatory submissions for three approved checkpoint inhibitors and advises the FDA on cell therapy policy.

Head of Data Science

Pfizer Research

Dr. Webb leads Pfizer's AI-powered clinical trial optimization program, reducing trial failure rates through predictive patient stratification.

Chief Scientific Officer

GenomicAI Inc.

Dr. Zhang applies deep learning to genomic variant interpretation and has built AI systems now used in over 500 clinical laboratories worldwide.

Professor of Cognitive Neuroscience

Stanford University

Dr. Nair's research uses ultra-high-field fMRI to map functional connectivity in the human brain, with a focus on attention and working memory networks.

Co-Founder & Chief AI Officer

AtomWise

Dr. Patel built the first deep learning platform for structure-based drug discovery, with compounds from his platform now in Phase II clinical trials.

Professor of Immuno-Oncology

MD Anderson Cancer Center

Dr. Weinstein is a pioneer in CAR-T cell therapy and has led Phase I/II trials for multiple hematologic malignancies with breakthrough therapy designations.

Professor of Genomic Medicine

Harvard Medical School

Dr. Chen is a leading authority on clinical genomics and has pioneered the use of whole-genome sequencing in rare disease diagnosis. Her lab has published over 200 papers in Nature, Science, and NEJM.

Chair of Bioethics

Karolinska Institute

A renowned bioethicist specializing in the societal implications of genetic technologies, germline editing, and genomic data privacy.

Professor of Computational Pharmacology

ETH Zurich

Prof. Sorokina develops generative models for de novo molecular design and has pioneered multi-target drug optimization algorithms.

Director, CRISPR Therapeutics Lab

Broad Institute

Prof. Okafor leads one of the world's most prolific CRISPR research programs. His team developed the first approved base-editing therapy for sickle cell disease.

Director, Alzheimer's Research Center

UCSF Memory & Aging Center

Prof. Hartmann has led landmark clinical trials for Alzheimer's disease therapeutics and is a pioneer in tau PET imaging for early diagnosis.

Head of Tumor Immunology

Memorial Sloan Kettering

Prof. Tanaka's research focuses on the immunosuppressive tumor microenvironment and strategies to reinvigorate exhausted T cells.